Many patients with high-risk biochemically recurrent prostate cancer based on PSA doubling time are unidentified in clinical practice. Clinicians unaware of patients’ PSA doubling time (PSADT) at ...

What happens to men with prostate cancer whose PSA starts to rise while on neo-adjuvant androgen ablation therapy prior to external radiation? No significant financial relationships to disclose. This ...

Mental distress, chronic fatigue, and neuroticism as significant predictors of side effects in prostate cancer patients after radical prostatectomy (RP) or high-dose radiotherapy (RAD). Background: ...

NEW YORK (Reuters Health) - A diet low in saturated fat, high in vegetable protein and low in animal protein, including dairy products, is associated with a "substantial" increase in prostate-specific ...

A 1-year period of intensified androgen receptor blockade prolonged prostate-specific antigen progression-free survival (PSA-PFS) compared with androgen deprivation therapy (ADT) alone for patients ...

Men with rising PSA following initial therapy for localized prostate cancer experienced an increase in PSA doubling time (PSADT) after being treated with pomegranate extract, according to a new study.

The increase in prostate cancer–specific survival associated with salvage radiotherapy was limited to men with PSA doubling time (a measurement of how aggressive the disease is) of less than 6 months.

Early initiation of continuous androgen-deprivation therapy (ADT) for prostate cancer patients who experience biochemical relapse may not meaningfully improve overall survival, according to new ...

Author(s)Hussain M, Fizazi K, Saad F, et al. Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer. N Engl J Med. 2018, 378(26):2465-2474. doi: 10.1056/NEJMoa1800536. Median ...

BOSTON -- A new Fox Chase Cancer Center study suggests men with early stage prostate cancer treated with radiation therapy should begin hormone therapy immediately if their PSA level rises quickly and ...